Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Medicenna Therapeutics Corp. (T.MDN) had Cash Flow from Financial Activities of 15.83M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
-3.05M |
|
-- |
|
-- |
|
-- |
|
-4.05M |
|
-- |
|
-3.05M |
|
-3.05M |
|
-3.05M |
|
-3.05M |
|
-3.05M |
|
-3.05M |
|
-4.05M |
|
-4.04M |
|
76.84M |
|
76.84M |
|
-0.04 |
|
-0.04 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
24.13M |
|
-- |
|
-- |
|
-- |
|
9.44M |
|
14.70M |
|
14.66M |
|
14.70M |
|
77.04M |
|
| Cash Flow Statement Financials | |
-5.82M |
|
-0.02M |
|
|
Cash Flow from Financial Activities |
15.83M |
12.45M |
|
22.30M |
|
9.85M |
|
0.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.40 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.77% |
|
-20.82% |
|
-12.65% |
|
-20.62% |
|
0.26 |
|
-0.08 |
|
-0.08 |
|